Table 2.

Patients with side effects in the two treatment regimens throughout the whole study perioda

OverallDGF Patients
Standard-Dose RATG (n = 16)Low-Dose RATG (n = 17)Standard-Dose RATG (n = 11)Low-Dose RATG (n = 11)
Fever93b73
WBC < 3500/mm39473
Hb reduction > 2 g/dl1584
    need for blood transfusions15c13d
    no. of per-patient transfused units2.1 ± 0.70.5 ± 0.4e2.9 ± 0.70.6 ± 0.6e
Infections1585
    CMV reactivations93b73
  • a WBC, white blood cell; Hb, hemoglobin; CMV, cytomegalovirus.

  • b P < 0.05,

  • c P = 0.01,

  • d P < 0.001,

  • e P < 0.001 versus standard-dose RATG.